Cardiovascular risks of androgen receptor targeted agents in prostate cancer: A systematic review and meta-analysis

被引：0
|
作者：
Ong, C. [1 ]
Law, Y. X. T. [1 ]
Kyaw, L. [1 ]
Lim, Q. Y. [1 ]
Loke, T. [2 ]
Wu, Q. H. [1 ]
Tiong, H. Y. [1 ]
Chiong, E. [1 ]
机构：
[1] Natl Univ Singapore Hosp, Dept Urol, Singapore, Singapore
[2] Ng Teng Fong Gen Hosp, Dept Urol, Singapore, Singapore
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0637
引用
收藏
页码：S1570 / S1570
页数：1
相关论文
共 50 条
  • [1] Cardiovascular risks of androgen receptor targeted agents in prostate cancer: a systematic review and meta-analysis
    Ong, Chloe Shu Hui
    Law, Yu Xi Terence
    Kyaw, Lin
    Lim, Qi Yang
    Loke, Tim
    Wu, Qing Hui
    Tiong, Ho Yee
    Chiong, Edmund
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (03) : 393 - 403
  • [2] Cardiovascular risks of androgen receptor targeted agents in prostate cancer: a systematic review and meta-analysis "PCAN-23-0763R"
    Yaxley, J. W.
    Fitzgerald, B.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024,
  • [3] Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer A Systematic Review and Meta-Analysis
    El-Taji, Omar
    Taktak, Samih
    Jones, Craig
    Brown, Mick
    Clarke, Noel
    Sachdeva, Ashwin
    JAMA ONCOLOGY, 2024, 10 (07) : 874 - 884
  • [4] Addition of androgen receptor targeted agents to androgen deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis
    Maiorano, B. A.
    De Giorgi, U.
    Roviello, G.
    Messina, C.
    Altavilla, A.
    Cattrini, C.
    Mennitto, A.
    Maiello, E.
    Di Maio, M.
    ESMO OPEN, 2022, 7 (05)
  • [5] Androgen Receptor Signaling Pathway Inhibitors and cardiovascular Events in metastatic Prostate Cancer: a systematic Review and Meta-analysis
    Uhlig, Annemarie
    UROLOGIE, 2024, 63 (12): : 1276 - 1280
  • [6] Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis
    Matsukawa, Akihiro
    Yanagisawa, Takafumi
    Parizi, Mehdi Kardoust
    Laukhtina, Ekaterina
    Klemm, Jakob
    Fazekas, Tamas
    Mori, Keiichiro
    Kimura, Shoji
    Briganti, Alberto
    Ploussard, Guillaume
    Karakiewicz, Pierre I.
    Miki, Jun
    Kimura, Takahiro
    Rajwa, Pawel
    Shariat, Shahrokh F.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024,
  • [7] Is androgen deprivation therapy for prostate cancer associated with cardiovascular disease? A meta-analysis and systematic review
    Liang, Zhen
    Zhu, Jun
    Chen, Longlong
    Xu, Yawei
    Yang, Yongjiao
    Hu, Rui
    Zhang, Wei
    Song, Yuxuan
    Lu, Yi
    Ou, Ningjing
    Liu, Xiaoqiang
    ANDROLOGY, 2020, 8 (03) : 559 - 574
  • [8] Cardiovascular Toxicity Associated With Androgen Receptor Axis-Targeted Agents in Patients With Prostate Cancer: A Meta-analysis of Randomized Controlled Trials
    Zhou, Susu
    Alerasool, Parissa
    Kishi, Noriko
    Joshi, Himanshu
    Sahni, Gagan
    Tsao, Che-Kai
    CLINICAL GENITOURINARY CANCER, 2024, 22 (03)
  • [9] Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents
    C. P. Escalante
    Y. C. Chang
    K. Liao
    T. Rouleau
    J. Halm
    P. Bossi
    S. Bhadriraju
    N. Brito-Dellan
    S. Sahai
    S. W. Yusuf
    A. Zalpour
    L. S. Elting
    Supportive Care in Cancer, 2016, 24 : 4057 - 4074
  • [10] Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents
    Escalante, C. P.
    Chang, Y. C.
    Liao, K.
    Rouleau, T.
    Halm, J.
    Bossi, P.
    Bhadriraju, S.
    Brito-Dellan, N.
    Sahai, S.
    Yusuf, S. W.
    Zalpour, A.
    Elting, L. S.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (09) : 4057 - 4074
12345